KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Flanigans Enterprises (BDL) Total Liabilities (2016 - 2025)

Flanigans Enterprises (BDL) has disclosed Total Liabilities for 15 consecutive years, with $62.4 million as the latest value for Q2 2025.

  • On a quarterly basis, Total Liabilities fell 6.91% to $62.4 million in Q2 2025 year-over-year; TTM through Jun 2025 was $62.4 million, a 6.91% decrease, with the full-year FY2024 number at $66.7 million, down 5.9% from a year prior.
  • Total Liabilities was $62.4 million for Q2 2025 at Flanigans Enterprises, down from $65.4 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $75.8 million in Q4 2022 to a low of $62.4 million in Q2 2025.
  • A 5-year average of $69.0 million and a median of $68.4 million in 2024 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: rose 27.63% in 2021, then decreased 6.91% in 2025.
  • Flanigans Enterprises' Total Liabilities stood at $67.4 million in 2021, then grew by 12.49% to $75.8 million in 2022, then dropped by 5.31% to $71.8 million in 2023, then decreased by 0.72% to $71.2 million in 2024, then decreased by 12.38% to $62.4 million in 2025.
  • Per Business Quant, the three most recent readings for BDL's Total Liabilities are $62.4 million (Q2 2025), $65.4 million (Q1 2025), and $71.2 million (Q4 2024).